This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: nicotinic acid

In brief – cardiology news roundup

March 2013 Br J Cardiol 2013;20:16-17

In brief – cardiology news roundup

BJCardio Staff

Abstract

New editorial board member Dr Ketan Dhatariya We are delighted to welcome Dr Ketan Dhatariya to our editorial board. Dr Dhatariya is a consultant in diabetes, endocrinology and general medicine at Norfolk and Norwich University Hospital, Norwich. He is also a senior lecturer at the University of East Anglia, and an assistant professor of medicine at St George’s University, Grenada, in the West Indies. He has published on a wide variety of diabetes- and endocrine-related subjects, including diabetes-related foot disease. He serves as meetings secretary for the Association of British Clinical Diabetologists, and medical secretary for the Spec

| Full text

September 2009 Br J Cardiol 2009;16:226

In brief

BJCardio editorial staff

Abstract

Nicotinic acid/laropiprant combination launched in UK A combination of nicotinic acid and laropiprant (Tredaptive®), for the treatment of dyslipidaemia (particularly combined mixed dyslipidaemia and primary hypercholesterolaemia) has been launched in the UK by Merck Sharp & Dohme. It should be used in combination with statins when the cholesterol-lowering effect of statin monotherapy is inadequate, and as monotherapy only if statins are thought inappropriate or if they are not tolerated. Diet and other non-pharmacological measures to control lipid levels should be continued. It is hoped that the addition of the anti-flushing agent laropi

| Full text

July 2006 Br J Cardiol 2006;13:273-7

Safety and tolerability of prolonged-release nicotinic acid combined with a statin in NAUTILUS

Anja Vogt, Ursula Kassner, Ulrike Hostalek, Elisabeth Steinhagen-Thiessen, on behalf of the NAUTILUS Study Group

Abstract

No content available

| Full text

March 2006 Br J Cardiol 2006;13:131-6

The failure of LDL cholesterol reduction and the importance of reverse cholesterol transport. The role of nicotinic acid

H Robert Superko

Abstract

No content available

| Full text

March 2005 Br J Cardiol 2005;12:118-22

Dyslipidaemia in ethnic populations: special considerations

Anthony H Barnett

Abstract

No content available

| Full text

November 2003 Br J Cardiol 2003;10:462-8

Modified-release nicotinic acid for dyslipidaemia: novel formulation improves tolerability and optimises efficacy

Michael Schachter

Abstract

No content available

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now